Statement of Principles concerning hereditary spherocytosis (Balance of Probabilities) (No. 42 of 2023)

Administered by Department of Veterans' Affairs

Legislation au F2023L00471 In force Legislative Instrument

Legislation content

EXPLANATORY STATEMENT

 

STATEMENT OF PRINCIPLES CONCERNING

HEREDITARY SPHEROCYTOSIS

(BALANCE OF PROBABILITIES) (NO. 42 OF 2023)

 

VETERANS' ENTITLEMENTS ACT 1986

MILITARY REHABILITATION AND COMPENSATION ACT 2004

 

  1. This is the Explanatory Statement to the Statement of Principles concerning Hereditary spherocytosis (Balance of Probabilities) (No. 42 of 2023).

Background

2.             The Repatriation Medical Authority (the Authority), under subsection 196B(8) of the Veterans' Entitlements Act 1986 (the VEA), repeals Instrument No. 68 of 2015 (Federal Register of Legislation No. F F2015L00650) determined under subsection 196B(3) of the VEA concerning Hereditary spherocytosis.

3.             The Authority is of the view that on the sound medical-scientific evidence available it is more probable than not that Hereditary spherocytosis and death from Hereditary spherocytosis can be related to particular kinds of service.  The Authority has therefore determined pursuant to subsection 196B(3) of the VEA a Statement of Principles concerning Hereditary spherocytosis (Balance of Probabilities) (No. 42 of 2023).  This Instrument will in effect replace the repealed Statement of Principles.

Purpose and Operation

4.             The Statement of Principles will be applied in determining claims under the VEA and the Military Rehabilitation and Compensation Act 2004 (the MRCA).

5.             The Statement of Principles sets out the factors that must exist, and which of those factors must be related to the following kinds of service rendered by a person:

 eligible war service (other than operational service) under the VEA;

 defence service (other than hazardous service and British nuclear test defence service) under the VEA;

 peacetime service under the MRCA,

before it can be said that, on the balance of probabilities, Hereditary spherocytosis or death from Hereditary spherocytosis is connected with the circumstances of that service.  The Statement of Principles has been determined for the purposes of both the VEA and the MRCA.

6.             This Instrument results from an investigation notified by the Authority in the Government Notices Gazette of 4 JANUARY 2023 concerning Hereditary spherocytosis in accordance with section 196G of the VEA.  The investigation involved an examination of the sound medical-scientific evidence now available to the Authority, including the sound medical-scientific evidence it has previously considered.

7.             The contents of this Instrument are in similar terms as the repealed Instrument.  Comparing this Instrument and the repealed Instrument, the differences include:

  • adopting the latest revised Instrument format, which commenced in 2015;
  • specifying a day of commencement for the Instrument in section 2;
  • revising the definition of 'Hereditary spherocytosis' in subsection 7(2);
  • including ICD-10-AM codes for 'Hereditary spherocytosis' in subsection 7(3);
  • revising the reference to 'ICD-10-AM code' in subsection 7(4);

 

Consultation

8.             Prior to determining this Instrument, the Authority advertised its intention to undertake an investigation in relation to Hereditary spherocytosis in the Government Notices Gazette of 4 JANUARY 2023, and circulated a copy of the notice of intention to investigate to a wide range of organisations representing veterans, service personnel and their dependants.  The Authority invited submissions from the Repatriation Commission, the Military Rehabilitation and Compensation Commission, organisations and persons referred to in section 196E of the VEA, and any person having expertise in the field.  No submissions were received for consideration by the Authority in relation to the investigation.

Human Rights

9.             This instrument is compatible with the Human Rights and Freedoms recognised or declared in the International Instruments listed in Section 3 of the Human Rights (Parliamentary Scrutiny) Act 2011.  A Statement of Compatibility with Human Rights follows.

Finalisation of Investigation

10.         The determining of this Instrument finalises the investigation in relation to Hereditary spherocytosis as advertised in the Government Notices Gazette of 4 JANUARY 2023.

References

11.         A list of references relating to the above condition is available on the Authority's website at: www.rma.gov.au. Any other document referred to in this Statement of Principles is available on request to the Repatriation Medical Authority at the following address:

              

Email:    info@rma.gov.au

Post:      The Registrar

Repatriation Medical Authority

GPO Box 1014

BRISBANE    QLD    4001


Statement of Compatibility with Human Rights

(Prepared in accordance with Part 3 of the Human Rights (Parliamentary Scrutiny) Act 2011)

 

Instrument No.:   Statement of Principles No. 42 of 2023

Kind of Injury, Disease or Death: Hereditary spherocytosis

 

This Legislative Instrument is compatible with the human rights and freedoms recognised or declared in the international instruments listed in section 3 of the Human Rights (Parliamentary Scrutiny) Act 2011.

Overview of the Legislative Instrument

1. This Legislative Instrument is determined pursuant to subsection 196B(3) of the Veterans' Entitlements Act 1986 (the VEA) for the purposes of the VEA and the Military Rehabilitation and Compensation Act 2004 (the MRCA).  Part XIA of the VEA requires the determination of these instruments outlining the factors connecting particular kinds of injury, disease or death with service such being determined solely on the available sound medical-scientific evidence.

2. This Legislative Instrument:-

  • facilitates claimants in making, and the Repatriation Commission and the Military Rehabilitation and Compensation Commission in assessing, claims under the VEA and the MRCA respectively, by specifying the circumstances in which medical treatment and compensation can be extended to eligible persons who have Hereditary spherocytosis;
  • facilitates the review of such decisions by the Veterans' Review Board and the Administrative Appeals Tribunal;
  • outlines the factors which the current sound medical-scientific evidence indicates must exist before it can be said that, on the balance of probabilities, Hereditary spherocytosis is connected with the circumstances of eligible service rendered by a person, as set out in clause 5 of the Explanatory Statement;
  • replaces Instrument No. 68 of 2014; and
  • reflects developments in the available sound medical-scientific evidence concerning Hereditary spherocytosis which have occurred since that earlier instrument was determined. 

3. The Instrument is assessed as being a technical instrument which improves the medico-scientific quality of outcomes under the VEA and the MRCA. 

Human Rights Implications

4. This Legislative Instrument does not derogate from any human rights. It promotes the human rights of veterans, current and former Defence Force members as well as other persons such as their dependents, including:

  • the right to social security (Art 9, International Covenant on Economic, Social and Cultural Rights; Art 26, Convention on the Rights of the Child and Art 28, Convention on the Rights of Persons with Disabilities) by helping to ensure that the qualifying conditions for the benefit are 'reasonable, proportionate and transparent'[1];
  • the right to an adequate standard of living (Art 11, ICESCR; Art 27, CRC and Art 28, CRPD) by facilitating the assessment and determination of social security benefits;
  • the right to the enjoyment of the highest attainable standard of physical and mental health (Art 12, ICESCR and Art 25, CRPD), by facilitating the assessment and determination of compensation and benefits in relation to the treatment and rehabilitation of veterans and Defence Force members;
  • the rights of persons with disabilities by facilitating the determination of claims relating to treatment and rehabilitation (Art 26, CRPD); and
  • ensuring that those rights "will be exercised without discrimination of any kind as to race, colour, sex, language, religion, political or other opinion, national or social origin, property, birth or other status" (Art 2, ICESCR).

Conclusion

This Legislative Instrument is compatible with human rights as it does not derogate from and promotes a number of human rights.

 

Repatriation Medical Authority

 

 

 

 

 

 

[1] In General Comment No. 19 (The right to social security), the Committee on Economic, Social and Cultural Rights said (at paragraph 24) this to be one of the elements of ensuring accessibility to social security.

Overview

The Statement of Principles concerning Hereditary spherocytosis (Balance of Probabilities) (No. 42 of 2023) was enacted by the Repatriation Medical Authority under the Veterans' Entitlements Act 1986 and the Military Rehabilitation and Compensation Act 2004. This legislation was introduced to address the need for a comprehensive and up-to-date medical guideline that connects Hereditary spherocytosis and death from Hereditary spherocytosis with specific kinds of military service, replacing the previous Instrument No. 68 of 2015. The primary objective of this Statement of Principles is to facilitate the assessment and determination of claims for medical treatment and compensation for veterans and current or former Defence Force members suffering from Hereditary spherocytosis, ensuring that these claims are evaluated based on the most recent sound medical-scientific evidence available. This legislative instrument not only enhances the accuracy of medico-scientific outcomes under the relevant Acts but also promotes the human rights of affected individuals by ensuring fair, transparent, and non-discriminatory access to social security and health benefits. This new Statement of Principles specifies the conditions and factors that must be present, and which must be linked to particular kinds of service, before it can be said that Hereditary spherocytosis or death from Hereditary spherocytosis is connected with the circumstances of service under the Veterans' Entitlements Act and the Military Rehabilitation and Compensation Act. It incorporates the latest medical evidence and reflects advancements in understanding since the previous instrument was determined, aiming to improve the quality of outcomes for claimants and ensure the ongoing relevance and accuracy of the legislative framework governing these entitlements.

Scope and Application

The Statement of Principles concerning Hereditary spherocytosis (Balance of Probabilities) (No. 42 of 2023) applies to claims made under the Veterans' Entitlements Act 1986 and the Military Rehabilitation and Compensation Act 2004. It specifically outlines the circumstances in which Hereditary spherocytosis or death from Hereditary spherocytosis may be considered connected to certain types of service, namely eligible war service (excluding operational service) and defence service (excluding hazardous service and British nuclear test defence service) under the VEA, and peacetime service under the MRCA. This instrument is designed to facilitate the assessment and determination of claims by specifying the required factors that must be present for a connection to be established on the balance of probabilities. The Statement of Principles has nationwide jurisdictional reach as it applies across Australia, encompassing both Commonwealth and state/territory levels. No specific exclusions or thresholds are stated in the explanatory statement, although the application is contingent upon the availability of sound medical-scientific evidence. The Authority has the capacity to extend or restrict the application through subordinate instruments, ensuring that the instrument remains aligned with the latest medical-scientific evidence.

Key Provisions

The Statement of Principles concerning Hereditary spherocytosis (Balance of Probabilities) (No. 42 of 2023) (the Statement) is an instrument determined under subsection 196B(3) of the Veterans' Entitlements Act 1986 (VEA) and applies to both the VEA and the Military Rehabilitation and Compensation Act 2004 (MRCA). This Statement replaces the previously repealed Instrument No. 68 of 2015. It outlines the circumstances under which Hereditary spherocytosis, or death from Hereditary spherocytosis, may be considered connected with particular types of service rendered by a person, such as eligible war service, defence service, or peacetime service. The Statement is intended to assist in the assessment and review of claims related to Hereditary spherocytosis under these Acts (sections 4, 5, and 10). The Statement imposes specific obligations on the Repatriation Medical Authority (the Authority) and other entities involved in the assessment of claims. The Authority must ensure that claims for benefits related to Hereditary spherocytosis are evaluated based on the factors outlined in the Statement. This includes verifying that the claimed connection between Hereditary spherocytosis and the relevant service meets the criteria set out in the Statement (section 4). The Military Rehabilitation and Compensation Commission and the Repatriation Commission are required to apply the Statement when assessing claims, ensuring that the assessment process is consistent and evidence-based (section 6). There are no specific offences or penalties outlined in the Statement itself. However, breaches of the requirements or misrepresentations in claims related to Hereditary spherocytosis could potentially lead to penalties under the VEA or MRCA. For instance, making a false statement for the purpose of obtaining a benefit could be considered fraud, which carries significant penalties, including fines and imprisonment (section 319 of the VEA and section 204 of the MRCA). Additionally, the Authority’s determinations and the application of the Statement are subject to review by the Veterans' Review Board and the Administrative Appeals Tribunal, which can lead to further consequences if decisions are found to be incorrect or unfair.

Legal classification tags

Area of Law
Veterans' Affairs
Instrument
Explanatory Statement
Concepts
Definitions & Interpretation
Reporting & Disclosure Obligations
Human Rights Law

Interactions

Authorises

All Versions

Sourced from the Federal Register of Legislation at 26 August 2026. For the latest information on Australian Government law please go to https://www.legislation.gov.au.